Ming Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ming Li has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Zhibo Li
Department of Cardiovascular Internal Medicine the Second Hospital of Jilin University Changchun China
1 shared publication- Zhuo Zhao
Department of Cardiovascular Internal Medicine the Second Hospital of Jilin University Changchun China
1 shared publication Ziyuan Guo
Department of Cardiovascular Internal Medicine the Second Hospital of Jilin University Changchun China
1 shared publication
Latest Publications
- 11 April 2026
- Published by Wiley in Reviews in Medical Virology
- Vol. 36 (3) , e70143
Oncovirus‐Driven Endothelial Plasticity: Endothelial‐to‐Mesenchymal Transition as a Hijacked Pathway in Oncoviral Cardiovascular Pathogenesis
Oncoviruses utilise various molecular strategies to modulate host cells and induce microenvironments that favour viral persistence, immune evasion, and disease progression. Endothelial‐to‐mesenchymal transition (EndMT) has recently emerged as a critical, yet underrecognized, pathway hijacked by oncoviral pathogens to modulate endothelial plasticity within the cardiovascular system. Accumulating evidence indicates that Oncogenic and non‐oncogenic viruses, including Kaposi's sarcoma–associated herpesvirus (KSHV/HHV‐8), severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), human immunodeficiency virus (HIV), and other endothelial‐tropic viruses, directly manipulate host signalling networks, such as TGF‐β, Wnt/β‐catenin, Notch, and NF‐κB, to induce partial or complete EndMT. This virus‐driven EndMT contributes to vascular remodelling, chronic inflammation, aberrant angiogenesis, and the development of oncoviral‐associated cardiovascular pathology and vascular tumours. The present review integrates current virological and mechanistic insights into EndMT as a hijacked host process, highlighting its role at the virus–host interface and discussing emerging antiviral and pathway‐targeted strategies aimed at limiting oncovirus‐mediated endothelial dysfunction.
- 11 April 2026
- Published by Wiley in Reviews in Medical Virology
- Vol. 36 (3) , e70143
Oncovirus‐Driven Endothelial Plasticity: Endothelial‐to‐Mesenchymal Transition as a Hijacked Pathway in Oncoviral Cardiovascular Pathogenesis
Oncoviruses utilise various molecular strategies to modulate host cells and induce microenvironments that favour viral persistence, immune evasion, and disease progression. Endothelial‐to‐mesenchymal transition (EndMT) has recently emerged as a critical, yet underrecognized, pathway hijacked by oncoviral pathogens to modulate endothelial plasticity within the cardiovascular system. Accumulating evidence indicates that Oncogenic and non‐oncogenic viruses, including Kaposi's sarcoma–associated herpesvirus (KSHV/HHV‐8), severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), human immunodeficiency virus (HIV), and other endothelial‐tropic viruses, directly manipulate host signalling networks, such as TGF‐β, Wnt/β‐catenin, Notch, and NF‐κB, to induce partial or complete EndMT. This virus‐driven EndMT contributes to vascular remodelling, chronic inflammation, aberrant angiogenesis, and the development of oncoviral‐associated cardiovascular pathology and vascular tumours. The present review integrates current virological and mechanistic insights into EndMT as a hijacked host process, highlighting its role at the virus–host interface and discussing emerging antiviral and pathway‐targeted strategies aimed at limiting oncovirus‐mediated endothelial dysfunction.